BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20976737)

  • 1. Rapid screening of ATP13A2 variant with high-resolution melting analysis.
    Funayama M; Tomiyama H; Wu RM; Ogaki K; Yoshino H; Mizuno Y; Hattori N
    Mov Disord; 2010 Oct; 25(14):2434-7. PubMed ID: 20976737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis.
    Pan LS; Wang Z; Ding D; Zhu XP; Leng HL; Deng XB; Xu YM
    Int J Neurosci; 2016; 126(7):593-9. PubMed ID: 26000924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China.
    Fei QZ; Cao L; Xiao Q; Zhang T; Zheng L; Wang XJ; Wang G; Zhou HY; Wang Y; Chen SD
    Neurosci Lett; 2010 May; 475(2):61-3. PubMed ID: 20227461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore.
    Lin CH; Tan EK; Chen ML; Tan LC; Lim HQ; Chen GS; Wu RM
    Neurology; 2008 Nov; 71(21):1727-32. PubMed ID: 19015489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease.
    Chan AY; Baum L; Tang NL; Lau CY; Ng PW; Hui KF; Mizuno Y; Kwan JY; Mok VC; Kuo SH
    J Clin Neurosci; 2013 May; 20(5):761-2. PubMed ID: 23522931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.
    Li G; Zhang Z; Xia H; Yang X
    Med Sci Monit; 2014 Nov; 20():2177-82. PubMed ID: 25374329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.
    Wang D; Gao H; Li Y; Jiang S; Yang X
    Biomed Res Int; 2020; 2020():6954820. PubMed ID: 33335927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP13A2 variability in Taiwanese Parkinson's disease.
    Chen CM; Lin CH; Juan HF; Hu FJ; Hsiao YC; Chang HY; Chao CY; Chen IC; Lee LC; Wang TW; Chen YT; Chen YT; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):720-9. PubMed ID: 21714071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP13A2 variants in early-onset Parkinson's disease patients and controls.
    Djarmati A; Hagenah J; Reetz K; Winkler S; Behrens MI; Pawlack H; Lohmann K; Ramirez A; Tadić V; Brüggemann N; Berg D; Siebner HR; Lang AE; Pramstaller PP; Binkofski F; Kostić VS; Volkmann J; Gasser T; Klein C
    Mov Disord; 2009 Oct; 24(14):2104-11. PubMed ID: 19705361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease.
    Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B
    Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP13A2 variability in Parkinson disease.
    Vilariño-Güell C; Soto AI; Lincoln SJ; Ben Yahmed S; Kefi M; Heckman MG; Hulihan MM; Chai H; Diehl NN; Amouri R; Rajput A; Mash DC; Dickson DW; Middleton LT; Gibson RA; Hentati F; Farrer MJ
    Hum Mutat; 2009 Mar; 30(3):406-10. PubMed ID: 19085912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ATP13A2 and PINK1 variants identified in Chinese patients with Parkinson's disease by whole-exome sequencing.
    Chen H; Jin YH; Xue YY; Chen YL; Chen YJ; Tao QQ; Wu ZY
    Neurosci Lett; 2020 Aug; 733():135075. PubMed ID: 32446772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease.
    Dos Santos AV; Pestana CP; Diniz KR; Campos M; Abdalla-Carvalho CB; de Rosso AL; Pereira JS; Nicaretta DH; de Carvalho WL; Dos Santos JM; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2010 Nov; 485(2):121-4. PubMed ID: 20816920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease.
    Guo Y; Deng X; Zheng W; Xu H; Song Z; Liang H; Lei J; Jiang X; Luo Z; Deng H
    Neurosci Lett; 2011 Sep; 501(3):185-7. PubMed ID: 21791235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease.
    Li NN; Wang L; Tan EK; Cheng L; Sun XY; Lu ZJ; Li JY; Zhang JH; Peng R
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1148-1152. PubMed ID: 27626775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson's disease in Black South African and Nigerian patients.
    Oluwole OG; Kuivaniemi H; Abrahams S; Haylett WL; Vorster AA; van Heerden CJ; Kenyon CP; Tabb DL; Fawale MB; Sunmonu TA; Ajose A; Olaogun MO; Rossouw AC; van Hillegondsberg LS; Carr J; Ross OA; Komolafe MA; Tromp G; Bardien S
    BMC Med Genet; 2020 Feb; 21(1):23. PubMed ID: 32019516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    Zhang Z; Burgunder JM; An X; Wu Y; Chen W; Zhang J; Wang Y; Xu Y; Gou Y; Yuan G; Mao X; Peng R
    Mov Disord; 2009 Oct; 24(13):1902-5. PubMed ID: 19672984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients.
    Li L; Funayama M; Tomiyama H; Li Y; Yoshino H; Sasaki R; Kokubo Y; Kuzuhara S; Mizuno Y; Hattori N
    Neurosci Lett; 2010 Aug; 479(3):245-8. PubMed ID: 20641165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.